BNTC icon

Benitec Biopharma
BNTC

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $1.85M invested in Benitec Biopharma in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.53M
2
+$40K
3
+$25.4K
4
Morgan Stanley
Morgan Stanley
New York
+$17.3K
5
UBS Group
UBS Group
Switzerland
+$533

Top Sellers

1
-$10K
2
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.53M
2
$137K
3
$101K
4
$40K
5
$27K
6
$8K
7
–
8
–